• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.12% Nasdaq Up 0.71%

    More On CANF

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    Financials

    Can-Fite BioPharma Ltd. (CANF)

    -NYSE MKT
    2.17 Up 0.02(0.93%) Apr 24, 4:00PM EDT
    |Pre-Market : 2.65 Up 0.48 (22.13%) 8:09AM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:2.15
    Open:2.18
    Bid:2.63 x 1200
    Ask:2.65 x 600
    1y Target Est:2.70
    Beta:4.22
    Next Earnings Date:N/A
    Day's Range:2.12 - 2.18
    52wk Range:1.85 - 5.83
    Volume:176,216
    Avg Vol (3m):268,713
    Market Cap:23.13M
    P/E (ttm):N/A
    EPS (ttm):-0.69
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CANF

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.21
    Quarterly EPS Est (Mar-15) :-0.05
    Mean Recommendation*:2.7
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of autoimmune-inflammatory, oncological, and ophthalmic diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback